← GE HealthCare Technologies Inc.

Annual Trend FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net income from continuing operations $2.3b $1.9b $1.6b $2.0b $2.2b
Net Income (Loss) Attributable to Parent $2.3b
$1.9b -16.44%
$1.6b -18.16%
$2.0b +27.10%
$2.1b +4.57%
Net Income (Loss) Available to Common Stockholders, Basic $2.3b
$1.9b -16.44%
$1.4b -27.71%
$2.0b +43.90%
$2.1b +4.57%
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest — $2.0b $1.6b $2.0b $2.2b
Net Income (Loss) Attributable to Noncontrolling Interest — $51.0m $46.0m $57.0m $70.0m
Depreciation — $228.0m $248.0m $268.0m $287.0m
Amortization of Intangible Assets $400.0m $405.0m $362.0m $312.0m $291.0m
Depreciation of property, plant, and equipment $225.0m $228.0m $248.0m $268.0m $287.0m
Share-based Payment Arrangement, Noncash Expense — $67.0m $114.0m $125.0m $130.0m
Payment, Tax Withholding, Share-based Payment Arrangement — — — $93.0m $42.0m
Share-based Payment Arrangement, Expense — — $114.0m $125.0m $130.0m
Share-based compensation $76.0m $67.0m $114.0m $125.0m $130.0m
Gain (Loss) on Sale of Assets and Asset Impairment Charges — ($26.0m) ($13.0m) ($17.0m) ($12.0m)
Goodwill, Impairment Loss — $0 — $0 $0
Impairment of Intangible Assets, Finite-lived — $0 $0 $0 $0
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) — $0 $0 $0 $0
Restructuring Costs and Asset Impairment Charges — $146.0m $54.0m $120.0m $120.0m
Income (Loss) from Equity Method Investments — $13.0m $11.0m $8.0m $3.0m
Other Nonoperating Income (Expense) — $62.0m $86.0m $55.0m $157.0m
Gain on remeasurement of Nihon Medi-Physics equity method investment — — $0 $0 ($97.0m)
Changes in operating assets and liabilities:
Receivables ($1.3b) ($231.0m) ($185.0m) ($178.0m) ($216.0m)
Increase (Decrease) in Inventories — $402.0m ($111.0m) $81.0m $142.0m
Inventories ($435.0m) ($402.0m) $111.0m ($81.0m) ($142.0m)
Increase (Decrease) in Accounts Payable — $481.0m ($13.0m) $126.0m $90.0m
Accounts payable $263.0m $481.0m ($13.0m) $126.0m $90.0m
All other operating activities – net $11.0m $103.0m $327.0m ($74.0m) ($204.0m)
Cash flows from investing activities:
Additions to property, plant and equipment and internal-use software $93.0m $136.0m $140.0m $143.0m $164.0m
Dispositions of property, plant, and equipment $15.0m $4.0m $1.0m $0 $0
Gain (Loss) on Investments — ($31.0m) $1.0m ($22.0m) $112.0m
Payments to Acquire Investments — — — $40.0m $118.0m
Purchases of investments — ($59.0m) ($48.0m) ($40.0m) ($118.0m)
Payments to Acquire Businesses, Net of Cash Acquired — $0 $147.0m $313.0m $378.0m
Payments for (Proceeds from) Other Investing Activities — $92.0m $25.0m $160.0m $69.0m
All other investing activities – net ($47.0m) ($92.0m) ($25.0m) ($160.0m) ($69.0m)
Net Cash Provided by (Used in) Investing Activities — ($398.0m) ($558.0m) ($914.0m) ($1.0b)
Cash flows from financing activities:
Net increase (decrease) in borrowings (maturities of 90 days or less) ($7.0m) $9.0m ($12.0m) $0 $1.0m
Newly issued debt, net of debt issuance costs (maturities longer than 90 days) $5.0m $8.2b $2.0b $995.0m $2.7b
Payments for Repurchase of Common Stock — — — — $200.0m
Repurchase of common stock — — $0 $0 ($200.0m)
Dividends paid — $0 $41.0m $55.0m $64.0m
Dividends paid to stockholders $0 $0 ($41.0m) ($55.0m) ($64.0m)
Proceeds from (Payments for) Other Financing Activities — ($92.0m) ($48.0m) ($34.0m) ($81.0m)
All other financing activities – net ($13.0m) ($92.0m) ($48.0m) ($34.0m) ($81.0m)
Net Cash Provided by (Used in) Financing Activities — ($822.0m)
($478.0m) +41.85%
($573.0m) -19.87%
$617.0m +207.68%
Increase (decrease) in cash, cash equivalents, and restricted cash ($451.0m) $890.0m $1.1b $387.0m $1.6b
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect — $890.0m $1.1b $387.0m $1.6b
Cash, cash equivalents, and restricted cash at beginning of year $561.0m $1.5b $2.5b $2.9b $4.5b
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — $1.5b $2.5b $2.9b $4.5b
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — ($3.0m) ($10.0m) ($77.0m) $66.0m
Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash ($34.0m) ($3.0m) ($10.0m) ($77.0m) $66.0m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Proceeds from Stock Options Exercised — — $34.0m $33.0m $37.0m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities ($21.0m) $0 $570.0m $550.0m $522.0m
Income Taxes Paid, Net ($615.0m) $851.0m $474.0m $491.0m $429.0m
Additional Financial Items
Foreign Currency Transaction Gain (Loss), before Tax — ($88.0m) $16.0m $16.0m ($149.0m)
Gain (Loss) on Disposition of Assets — $1.0m $0 $0 $5.0m
Goodwill — $12.8b $12.9b $13.1b $13.5b
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent — $1.9b $1.6b $2.0b $2.1b
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest — $1.9b $1.6b $2.0b $2.2b
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest — $18.0m ($4.0m) $0 $0
Income Tax Expense (Benefit) — $563.0m $743.0m $531.0m $614.0m
Operating Expenses — $4.7b $5.5b $5.6b $5.5b
Less: Income (loss) from discontinued operations, net of taxes $18.0m $18.0m ($4.0m) $0 $0
Net periodic postretirement benefit plan (income) expense $25.0m $9.0m ($332.0m) ($357.0m) ($267.0m)
Postretirement plan contributions ($20.0m) ($18.0m) ($357.0m) ($332.0m) ($338.0m)
Provision for income taxes $600.0m $563.0m $743.0m $531.0m $614.0m
Contract and other deferred assets $23.0m ($222.0m) $10.0m $3.0m ($60.0m)
Contract liabilities ($21.0m) $138.0m $26.0m $68.0m $81.0m
Current compensation and benefits — ($37.0m) $153.0m $39.0m $94.0m
Purchases of businesses, net of cash acquired ($1.5b) $0 ($147.0m) ($313.0m) ($378.0m)
Cash from (used for) investing activities – continuing operations ($1.8b) ($398.0m) ($558.0m) ($914.0m) ($1.0b)
Repayments and other reductions (maturities longer than 90 days) ($10.0m) ($3.0m) ($855.0m) ($1.4b) ($1.8b)
Redemption of noncontrolling interests $0 $0 ($211.0m) $0 $0
Net transfers (to) from GE ($238.0m) ($8.9b) ($1.3b) $0 $0
Proceeds from stock issued under employee benefit plans — $0 $34.0m $33.0m $37.0m
Cash from (used for) financing activities – continuing operations ($263.0m)
($822.0m) -212.55%
($478.0m) +41.85%
($573.0m) -19.87%
$617.0m +207.68%

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.